Phoenix Financial’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$244K Buy
3,878
+25
+0.6% +$1.74K ﹤0.01% 427
2025
Q4
$256K Buy
+3,853
New +$249K ﹤0.01% 408
2024
Q3
Sell
-1,818
Closed -$207K 379
2024
Q2
$207K Sell
1,818
-13,974
-88% -$1.77M ﹤0.01% 321
2024
Q1
$2.19M Buy
15,792
+322
+2% +$40.5K 0.03% 182
2023
Q4
$2.14M Buy
15,470
+2,167
+16% +$221K 0.04% 184
2023
Q3
$1.24M Sell
13,303
-1,912
-13% -$216K 0.02% 218
2023
Q2
$1.95M Buy
15,215
+2,659
+21% +$322K 0.04% 167
2023
Q1
$1.46M Buy
12,556
+4,940
+65% +$553K 0.03% 167
2022
Q4
$860K Sell
7,616
-881
-10% -$96.7K 0.02% 193
2022
Q3
$1.05M Sell
8,497
-2,866
-25% -$243K 0.02% 192
2022
Q2
$847K Buy
11,363
+1,187
+12% +$108K 0.02% 241
2022
Q1
$1.3M Buy
10,176
+6,680
+191% +$731K 0.02% 237
2021
Q4
$472K Sell
3,496
-752
-18% -$108K 0.01% 291
2021
Q3
$578K Buy
+4,248
New +$536K 0.01% 305
2021
Q2
Sell
-4,788
Closed -$416K 330
2021
Q1
$416K Sell
4,788
-1,628
-25% -$153K 0.01% 325
2020
Q4
$580K Buy
6,416
+3,160
+97% +$282K 0.02% 250
2020
Q3
$309K Buy
+3,256
New +$340K 0.01% 258

Other funds holding DXCM

Phoenix Financial's DXCM Position: Q1 2026 in Review

Phoenix Financial increased its DexCom (DXCM) stake by 0.65% in Q1 2026, buying an estimated $1.74K and bringing the position to 3,878 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #427.

Phoenix Financial first reported a position in DXCM in Q3 2020 and has held it in 17 quarters since. The position peaked at $2.19M in Q1 2024. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Phoenix Financial held 3,878 shares of DexCom worth $244K as of Q1 2026.
  • Phoenix Financial bought 25 DexCom shares in Q1 2026, an estimated $1.74K.
  • DexCom made up ﹤0.01% of Phoenix Financial's portfolio in Q1 2026, its #427 holding.
  • Phoenix Financial first reported a position in DexCom in Q3 2020 and has held it in 17 quarters since.
  • Phoenix Financial's DexCom position peaked at $2.19M in Q1 2024.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.